Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Single Cycle of Blinatumomab Followed By High-Dose Chemotherapy in the Induction Therapy for Ph-Negative Acute Lymphoblastic Leukemia in Adults. Primary Endpoint Analysis of the Blina-Cell Trial

Cyril Salek, Frantisek Folber, Stepan Hrabovsky, Zdenek Koristek, Jan M Horacek, Eva Fronkova, Petr Soukup, Katerina Benkova, Petr Cetkovsky, Jan Trka, Michael Doubek

Blood (2022) 140 (Supplement 1): 3258–3259.

https://doi.org/10.1182/blood-2022-157361

Published: 2022

Journal Articles

Methscore As a New Prognostic Tool for Complex DNA Methylation Changes Assessment in Patients with Acute Myeloid Leukemia

Sarka Sestakova, Cyril Šálek, MD, Dávid Kundrát, Ivana Ježíšková, Jiří Mayer, Zdeněk Ráčil, Petr Cetkovský, Hana Remešová

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-137380

Published: 2020

Journal Articles

Characteristics and Outcome of Patients with Core Binding Factor Acute Myeloid Leukemia and FLT3 -ITD: Results from an International Collaboration

Sabine Kayser, MD, Michelle A Elliott, MD, Marlise Luskin, MDMS, Andrew M. Brunner, MD, Michael Kramer, M.Sc., Zdenek Racil, MD, Zuzana Sustkova, MD, Petr Cetkovsky, MD MBA, PhD, Jan Novak, MD PhD, Friedrich Stoelzel, MD, Christian Thiede, MD, Carsten Müller-Tidow, MD, Uwe Platzbecker, Christoph Röllig, MD MSC, Richard F. Schlenk, MD, Mark J. Levis, MD

Blood (2019) 134 (Supplement_1): 2693.

https://doi.org/10.1182/blood-2019-125317

Published: 2019

Journal Articles

Interleukin 21 Enhances Survival and Expansion of CAR T Cells Via Inhibition of Their Terminal Differentiation during Interaction with Tumor Target Cells

Martin Štach, Jan Musil, Petr Cetkovsky, MD MBA, PhD, Pavel Otahal, MD PhD

Blood (2018) 132 (Supplement 1): 4545.

https://doi.org/10.1182/blood-2018-99-116294

Published: 2018

Journal Articles

An Analysis of Real Life Data Obtained from 30 Years Follow-up of Primary Myelodysplastic Syndromes (MDS) Patients Confirms a Leading Role of Stem Cell Transplantation (SCT) for Achievement of Prolonged Survival

Jaroslav Cermak, MD PhD, Antonin Vitek, MD, Dana Mikulenkova, MD, Jacqueline Soukupova, MD, Jana Brezinova, Marketa Stastna, MD PhD, Veronika Valkova, MD PhD, Monika Belickova, PhD, Kyra Michalova, PhD, Petr Cetkovsky, MD MBA, PhD

Blood (2018) 132 (Supplement 1): 4372.

https://doi.org/10.1182/blood-2018-99-114987

Published: 2018

Journal Articles

HLA Class I-Specific Effects in AML with Mutated Nucleophosmin

Kateřina Kuželová, PhD, Christoph Röllig, MD, Zdenek Racil, MD, Juliane S. Stickel, MD, Barbora Brodská, PhD, Johannes Schetelig, MD MSc, Christian Thiede, MD, Gerhard Ehninger, MD, Grzegorz Helbig, MD PhD, Slawomira Kyrcz-Krzemien, Prof, Jiri Mayer, Petr Cetkovsky, MD MBA, PhD

Blood (2016) 128 (22): 5230.

https://doi.org/10.1182/blood.V128.22.5230.5230

Published: 2016

Journal Articles

Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin

Katerina Kuzelova, PhD, Barbora Brodská, PhD, Jana Marková, Grzegorz Helbig, MD PhD, Slawomira Kyrcz-Krzemien, MD PhD, Petr Cetkovsky, MD MBA, PhD

Blood (2015) 126 (23): 2572.

https://doi.org/10.1182/blood.V126.23.2572.2572

Published: 2015

Journal Articles

Hematopoietic Cell Transplantation after TBI, Fludarabine, Idarubicine and Cytarabine Myeloablative Conditioning in Patients with Acute Myeloid Leukemia

Jan Vydra, MD, Veronika Válková, MD, Markéta ťastná Marková, MD, Ludmila Nováková, MD, Jiří Schwarz, MD PhD, Cyril álek, MD PhD, Antonín Vítek, MD, Petr Cetkovský, MD PhD Prof., Jaroslav Čermák, MD PhD, Kyra Michalová, Prof.

Blood (2014) 124 (21): 5847.

https://doi.org/10.1182/blood.V124.21.5847.5847

Published: 2014

Journal Articles

Comparison of Glucose and Lipid Metabolism Abnormality during Nilotinib, Imatinib and Dasatinib Therapy – Results of Enigma 2 Study

Racil Zdenek, Petra Belohlavkova, Petr Cetkovsky, Edgar Faber, Hana Klamova, Malaskova Ludmila, Tomasz Sacha, MD PhD, Voglova Jaroslava, Daniela Zackova, Pavel Zak, Jiri Mayer

Blood (2014) 124 (21): 1813.

https://doi.org/10.1182/blood.V124.21.1813.1813

Published: 2014

Journal Articles

CBFβ/MYH11 Hypomethylation Signature In Patients With Acute Myeloid Leukaemia

Hana Hajkova, Markus H.-Y. Fritz, Jiri Schwarz, Jana Markova, Martin Vostry, Zdenek Krejcik, Cyril Salek, Ota Fuchs, PhD, Petr Cetkovsky, Jaroslav Cermak, Cedrik Haskovec, Vladimir Benes

Blood (2013) 122 (21): 3774.

https://doi.org/10.1182/blood.V122.21.3774.3774

Published: 2013

Journal Articles

The Gene Expressions of hOCT1 and ABCB1 Change During the Course of CML in Relation to Imatinib Therapy

Katerina Machova Polakova, Jitka Koblihova, Zuzana Ondrackova, Filip Razga, Vaclava Polivkova, Hana Klamova, Daniela Zackova, Petr Cetkovsky, Marek Trneny, Jiri Mayer, Zdenek Racil

Blood (2011) 118 (21): 2495.

https://doi.org/10.1182/blood.V118.21.2495.2495

Published: 2011

Journal Articles

Significance of Minimal Residual Disease Monitored by Quantitative Assessment of WT1gene in Patients in First Remission of Acute Myeloid Leukemia Before Allogeneic Stem Cell Transplantation

Veronika Válková, Jaroslav Polak, Marketa Markova, Hana Hájková, Antonin Vitek, Mariana Hricinová, Dana Mikulenková, Jaroslav Cermak, MD, PhD, Petr Cetkovsky

Blood (2011) 118 (21): 4485.

https://doi.org/10.1182/blood.V118.21.4485.4485

Published: 2011

Journal Articles

Combination Chemotherapy Leading In Advanced MDS Patients to a Rapid Clearence of Bone Marrow Blasts Prior Stem Cell transplantation (SCT) Is Superior to up-Front SCT Even with Intensified Conditioning for Long-Term Survival

Jaroslav Cermak, Antonin Vitek, Marketa Markova, Petr Cetkovsky

Blood (2010) 116 (21): 4020.

https://doi.org/10.1182/blood.V116.21.4020.4020

Published: 2010

Journal Articles

Clinical Manifestation of 1000 Leukemias.

Zdenek Racil, MD, PhD, Jiri Mayer, Prof., MD, PhD, Martin Brejcha, MD, Petr Cetkovsky, MD., PhD., Jirina Prochazkova, Rene Zounar

Blood (2009) 114 (22): 4134.

https://doi.org/10.1182/blood.V114.22.4134.4134

Published: 2009

Journal Articles

Molecular Variability of FLT3/ITD Mutants and Their Impact on the Differentiation Program of 32D Cells: Implications for the Biological Properties of AML Blasts

Sona Pekova, M.D., PhD., Michal Dvorak, PhD., Robert Ivanek, Sabrina Rueggeberg, Stefan Leicht, Tomas Kozak, MD, PhD, Jiri Vrba, MD., Jiri Schwarz, MD., PHD., Petr Cetkovsky, MD., PHD., Miroslav Prucha, MD., PHD., Ondrej Hrusak

Blood (2008) 112 (11): 4480.

https://doi.org/10.1182/blood.V112.11.4480.4480

Published: 2008

Journal Articles

A Limited Impact of Chemotherapy on Prolonged Survival in Myelodysplasia (MDS). An Analysis of 142 Patients with Advanced Disease.

Jaroslav Cermak, MD, PhD, Antonin Vitek, MD, Marcela Lukasova, MD, Petr Cetkovsky, MD,PhD, Pavel Klener, MD,PhD

Blood (2006) 108 (11): 2677.

https://doi.org/10.1182/blood.V108.11.2677.2677

Published: 2006

Journal Articles

Achievement of Low or Intermediate-1 Risk Score after Combination Chemotherapy before Stem Cell Transplantation (SCT) May Be Associated with Prolonged Disease-Free Survival (DFS) in Patients with Advanced Myelodysplastic Syndrome (MDS).

Jaroslav Cermak, M.D., Ph.D., Antonin Vitek, M.D., Marcela Lukasova, M.D., Kyra Michalova, Ph.D., Petr Cetkovsky, M.D., Ph.D.

Blood (2004) 104 (11): 1443.

https://doi.org/10.1182/blood.V104.11.1443.1443

Published: 2004

NARROW

Single Cycle of Blinatumomab Followed By High-Dose Chemotherapy in the Induction Therapy for Ph-Negative Acute Lymphoblastic Leukemia in Adults. Primary Endpoint Analysis of the Blina-Cell Trial

Methscore As a New Prognostic Tool for Complex DNA Methylation Changes Assessment in Patients with Acute Myeloid Leukemia

Characteristics and Outcome of Patients with Core Binding Factor Acute Myeloid Leukemia and FLT3 -ITD: Results from an International Collaboration

Interleukin 21 Enhances Survival and Expansion of CAR T Cells Via Inhibition of Their Terminal Differentiation during Interaction with Tumor Target Cells

An Analysis of Real Life Data Obtained from 30 Years Follow-up of Primary Myelodysplastic Syndromes (MDS) Patients Confirms a Leading Role of Stem Cell Transplantation (SCT) for Achievement of Prolonged Survival

HLA Class I-Specific Effects in AML with Mutated Nucleophosmin

Immune Response in Acute Myeloid Leukemia with Mutated Nucleophosmin

Hematopoietic Cell Transplantation after TBI, Fludarabine, Idarubicine and Cytarabine Myeloablative Conditioning in Patients with Acute Myeloid Leukemia

Comparison of Glucose and Lipid Metabolism Abnormality during Nilotinib, Imatinib and Dasatinib Therapy – Results of Enigma 2 Study

CBFβ/MYH11 Hypomethylation Signature In Patients With Acute Myeloid Leukaemia

The Gene Expressions of hOCT1 and ABCB1 Change During the Course of CML in Relation to Imatinib Therapy

Significance of Minimal Residual Disease Monitored by Quantitative Assessment of WT1gene in Patients in First Remission of Acute Myeloid Leukemia Before Allogeneic Stem Cell Transplantation

Combination Chemotherapy Leading In Advanced MDS Patients to a Rapid Clearence of Bone Marrow Blasts Prior Stem Cell transplantation (SCT) Is Superior to up-Front SCT Even with Intensified Conditioning for Long-Term Survival

Clinical Manifestation of 1000 Leukemias.

Molecular Variability of FLT3/ITD Mutants and Their Impact on the Differentiation Program of 32D Cells: Implications for the Biological Properties of AML Blasts

A Limited Impact of Chemotherapy on Prolonged Survival in Myelodysplasia (MDS). An Analysis of 142 Patients with Advanced Disease.

Achievement of Low or Intermediate-1 Risk Score after Combination Chemotherapy before Stem Cell Transplantation (SCT) May Be Associated with Prolonged Disease-Free Survival (DFS) in Patients with Advanced Myelodysplastic Syndrome (MDS).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only